Skip to main content
Top
Published in: International Urology and Nephrology 8/2015

01-08-2015 | Nephrology - Original Paper

Serum paraoxonase activity is associated with epicardial fat tissue in renal transplant recipients

Authors: Eray Eroglu, Ismail Kocyigit, Aydin Unal, Hafsa Korkar, Cigdem Karakukcu, Ozcan Orscelik, Murat Hayri Sipahioglu, Bulent Tokgoz, Oktay Oymak

Published in: International Urology and Nephrology | Issue 8/2015

Login to get access

Abstract

Aims

Cardiovascular disease is a major cause of mortality in renal transplant recipients. Paraoxonase-1 (PON-1) has been shown to protect against atherosclerosis by modifying lipoproteins. Epicardial fat tissue (EFT) has been proposed as a new cardiovascular risk factor. The aim of this study was to investigate the relationship between PON-1 activity and EFT in renal transplant recipients.

Methods

Eighty renal transplant recipients were enrolled in this cross-sectional study. PON-1 activity was assessed from the rate of enzymatic hydrolysis of paraoxon to p-nitrophenol. EFT was measured by echocardiography.

Results

The mean age of the patients was 40.4 ± 12.3 years and mean post transplant follow-up duration was 57.2 ± 46 months. Mean PON-1 activity was 68.5 ± 30 U/L. PON-1 activity was positively correlated with age and body mass index and negatively correlated with parathyroid hormone, dialysis duration and EFT. The mean EFT thickness was 0.64 ± 0.17 cm. Multiple linear regression analysis was used to define independent determinants of EFT in renal transplant recipients. According to linear regression analysis, PON-1 levels and age were found to be independent predictors of EFT.

Conclusion

Reduced PON-1 activity was negatively associated with EFT and PON-1 activity independently predicts EFT in renal transplant recipients.
Literature
1.
go back to reference Lentine KL, Hurst FP, Jindal RM, Villines TC, Kunz JS, Yuan CM, Hauptman PJ, Abbott KC (2010) Cardiovascular risk assessment among potential kidney transplant candidates: approaches and controversies. Am J Kidney Dis 55(1):152–167PubMedCentralPubMedCrossRef Lentine KL, Hurst FP, Jindal RM, Villines TC, Kunz JS, Yuan CM, Hauptman PJ, Abbott KC (2010) Cardiovascular risk assessment among potential kidney transplant candidates: approaches and controversies. Am J Kidney Dis 55(1):152–167PubMedCentralPubMedCrossRef
2.
go back to reference Ghanta M, Kozicky M, Jim B (2015) Pathophysiologic and treatment strategies for cardiovascular disease in end-stage renal disease and kidney transplantations. Cardiol Rev 23(3):109–118 Ghanta M, Kozicky M, Jim B (2015) Pathophysiologic and treatment strategies for cardiovascular disease in end-stage renal disease and kidney transplantations. Cardiol Rev 23(3):109–118
3.
go back to reference Hotta K, Harada H, Sasaki H, Iwami D, Fukuzawa N, Morita K, Seki T, Togashi M, Nonomura K (2012) Successful kidney transplantation ameliorates arterial stiffness in end-stage renal disease patients. Transplant Proc 44(3):684–686PubMedCrossRef Hotta K, Harada H, Sasaki H, Iwami D, Fukuzawa N, Morita K, Seki T, Togashi M, Nonomura K (2012) Successful kidney transplantation ameliorates arterial stiffness in end-stage renal disease patients. Transplant Proc 44(3):684–686PubMedCrossRef
4.
go back to reference Stompór T, Rajzer M, Kawecka-Jaszcz K, Dembińska-Kieć A, Janda K, Wójcik K, Tabor B, Zdzienicka A, Grzybowska EJ, Sulowicz W (2005) Renal transplantation ameliorates the progression of arterial stiffness in patients treated with peritoneal dialysis. Perit Dial Int 25(5):492–496PubMed Stompór T, Rajzer M, Kawecka-Jaszcz K, Dembińska-Kieć A, Janda K, Wójcik K, Tabor B, Zdzienicka A, Grzybowska EJ, Sulowicz W (2005) Renal transplantation ameliorates the progression of arterial stiffness in patients treated with peritoneal dialysis. Perit Dial Int 25(5):492–496PubMed
5.
go back to reference Delahousse M, Chaignon M, Mesnard L, Boutouyrie P, Safar ME, Lebret T, Pastural-Thaunat M, Tricot L, Kolko-Labadens A, Karras A, Haymann JP (2008) Aortic stiffness of kidney transplant recipients correlates with donor age. J Am Soc Nephrol 19(4):798–805PubMedCentralPubMedCrossRef Delahousse M, Chaignon M, Mesnard L, Boutouyrie P, Safar ME, Lebret T, Pastural-Thaunat M, Tricot L, Kolko-Labadens A, Karras A, Haymann JP (2008) Aortic stiffness of kidney transplant recipients correlates with donor age. J Am Soc Nephrol 19(4):798–805PubMedCentralPubMedCrossRef
6.
go back to reference Kneifel M, Scholze A, Burkert A, Offermann G, Rothermund L, Zidek W, Tepel M (2006) Impaired renal allograft function is associated with increased arterial stiffness in renal transplant recipients. Am J Transplant 6(7):1624–1630PubMedCrossRef Kneifel M, Scholze A, Burkert A, Offermann G, Rothermund L, Zidek W, Tepel M (2006) Impaired renal allograft function is associated with increased arterial stiffness in renal transplant recipients. Am J Transplant 6(7):1624–1630PubMedCrossRef
7.
go back to reference Rosenblat M, Volkova N, Aviram M (2011) Injection of paraoxonase 1 (PON1) to mice stimulates their HDL and macrophage antiatherogenicity. Biofactors 37(6):462–467PubMedCrossRef Rosenblat M, Volkova N, Aviram M (2011) Injection of paraoxonase 1 (PON1) to mice stimulates their HDL and macrophage antiatherogenicity. Biofactors 37(6):462–467PubMedCrossRef
8.
go back to reference Tang WH, Hartiala J, Fan Y, Wu Y, Stewart AF, Erdmann J, Kathiresan S, CARDIoGRAM Consortium, Roberts R, McPherson R, Allayee H, Hazen SL (2012) Clinical and genetic association of serum paraoxonase and arylesterase activities with cardiovascular risk. Arterioscler Thromb Vasc Biol 32(11):2803–2812PubMedCentralPubMedCrossRef Tang WH, Hartiala J, Fan Y, Wu Y, Stewart AF, Erdmann J, Kathiresan S, CARDIoGRAM Consortium, Roberts R, McPherson R, Allayee H, Hazen SL (2012) Clinical and genetic association of serum paraoxonase and arylesterase activities with cardiovascular risk. Arterioscler Thromb Vasc Biol 32(11):2803–2812PubMedCentralPubMedCrossRef
9.
go back to reference Dantoine TF, Debord J, Charmes JP, Merle L, Marquet P, Lachatre G, Leroux-Robert C (1998) Decrease of serum paraoxonase activity in chronic renal failure. J Am Soc Nephrol 9(11):2082–2088PubMed Dantoine TF, Debord J, Charmes JP, Merle L, Marquet P, Lachatre G, Leroux-Robert C (1998) Decrease of serum paraoxonase activity in chronic renal failure. J Am Soc Nephrol 9(11):2082–2088PubMed
10.
go back to reference Sztanek F, Seres I, Harangi M, Lőcsey L, Padra J, Paragh GJ, Asztalos L, Paragh G (2012) Decreased paraoxonase 1 (PON1) lactonase activity in hemodialyzed and renal transplanted patients. A novel cardiovascular biomarker in end-stage renal disease. Nephrol Dial Transplant 27(7):2866–2872PubMedCrossRef Sztanek F, Seres I, Harangi M, Lőcsey L, Padra J, Paragh GJ, Asztalos L, Paragh G (2012) Decreased paraoxonase 1 (PON1) lactonase activity in hemodialyzed and renal transplanted patients. A novel cardiovascular biomarker in end-stage renal disease. Nephrol Dial Transplant 27(7):2866–2872PubMedCrossRef
11.
go back to reference Gungor O, Kismali E, Sisman AR, Kircelli F, Asci G, Topal K, Sipahi S, Tuncel P, Ozkahya M, Toz H (2013) The associations between serum paraoxonase 1 activity and carotid atherosclerosis in renal transplant patients. Clin Nephrol 80(3):198–202PubMedCrossRef Gungor O, Kismali E, Sisman AR, Kircelli F, Asci G, Topal K, Sipahi S, Tuncel P, Ozkahya M, Toz H (2013) The associations between serum paraoxonase 1 activity and carotid atherosclerosis in renal transplant patients. Clin Nephrol 80(3):198–202PubMedCrossRef
12.
go back to reference Iacobellis G, Corradi D, Sharma AM (2005) Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart. Nat Clin Pract Cardiovasc Med 2(10):536–543PubMedCrossRef Iacobellis G, Corradi D, Sharma AM (2005) Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart. Nat Clin Pract Cardiovasc Med 2(10):536–543PubMedCrossRef
13.
go back to reference Mazurek T, Zhang L, Zalewski A, Mannion JD, Diehl JT, Arafat H, Sarov-Blat L, O’Brien S, Keiper EA, Johnson AG, Martin J, Goldstein BJ, Shi Y (2003) Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 108(20):2460–2466PubMedCrossRef Mazurek T, Zhang L, Zalewski A, Mannion JD, Diehl JT, Arafat H, Sarov-Blat L, O’Brien S, Keiper EA, Johnson AG, Martin J, Goldstein BJ, Shi Y (2003) Human epicardial adipose tissue is a source of inflammatory mediators. Circulation 108(20):2460–2466PubMedCrossRef
14.
go back to reference Katsiki N, Mikhailidis DP, Wierzbicki AS (2013) Epicardial fat and vascular risk: a narrative review. Curr Opin Cardiol 28(4):458–463PubMedCrossRef Katsiki N, Mikhailidis DP, Wierzbicki AS (2013) Epicardial fat and vascular risk: a narrative review. Curr Opin Cardiol 28(4):458–463PubMedCrossRef
15.
go back to reference Turan MN, Gungor O, Asci G, Kircelli F, Acar T, Yaprak M, Ceylan N, Demirci MS, Bayraktaroglu S, Toz H, Ozkahya M, Ok E (2013) Epicardial adipose tissue volume and cardiovascular disease in hemodialysis patients. Atherosclerosis 226(1):129–133PubMedCrossRef Turan MN, Gungor O, Asci G, Kircelli F, Acar T, Yaprak M, Ceylan N, Demirci MS, Bayraktaroglu S, Toz H, Ozkahya M, Ok E (2013) Epicardial adipose tissue volume and cardiovascular disease in hemodialysis patients. Atherosclerosis 226(1):129–133PubMedCrossRef
16.
go back to reference Turkmen K, Ozbek O, Kayrak M, Samur C, Guler I, Tonbul HZ (2013) Peri-aortic fat tissue thickness in peritoneal dialysis patients. Perit Dial Int 33(3):316–324PubMedCentralPubMedCrossRef Turkmen K, Ozbek O, Kayrak M, Samur C, Guler I, Tonbul HZ (2013) Peri-aortic fat tissue thickness in peritoneal dialysis patients. Perit Dial Int 33(3):316–324PubMedCentralPubMedCrossRef
17.
go back to reference Colak H, Kilicarslan B, Tekce H, Tanrisev M, Tugmen C, Aktas G, Kursat S (2015) Relationship between epicardial adipose tissue, inflammation and volume markers in hemodialysis and transplant patients. Ther Apher Dial 19(1):56–62PubMedCrossRef Colak H, Kilicarslan B, Tekce H, Tanrisev M, Tugmen C, Aktas G, Kursat S (2015) Relationship between epicardial adipose tissue, inflammation and volume markers in hemodialysis and transplant patients. Ther Apher Dial 19(1):56–62PubMedCrossRef
18.
go back to reference Burtis CA, Ashwood ER. (1994) Tietz textbook of clinical chemistry, ed 2, Philadelphia, WB Saunders Burtis CA, Ashwood ER. (1994) Tietz textbook of clinical chemistry, ed 2, Philadelphia, WB Saunders
19.
go back to reference Lolekha PH, Chittamma A, Roberts WL, Sritara P, Cheepudomwit S, Suriyawongpaisal P (2005) Comparative study of two automated high-sensitivity C-reactive protein methods in a large population. Clin Biochem 38(1):31–35PubMedCrossRef Lolekha PH, Chittamma A, Roberts WL, Sritara P, Cheepudomwit S, Suriyawongpaisal P (2005) Comparative study of two automated high-sensitivity C-reactive protein methods in a large population. Clin Biochem 38(1):31–35PubMedCrossRef
20.
go back to reference Gutiérrez G, Jou JM, Carlos Reverter J, Martínez-Brotons F, Domingo A, Antonio Iriarte J, Remacha A, Rey J, Vives Corrons JL (1996) standardization committee for haematology. External quality assurance program for general hematology. Evaluation of the 1994 results. Sangre (Barc) 41(2):115–123 Gutiérrez G, Jou JM, Carlos Reverter J, Martínez-Brotons F, Domingo A, Antonio Iriarte J, Remacha A, Rey J, Vives Corrons JL (1996) standardization committee for haematology. External quality assurance program for general hematology. Evaluation of the 1994 results. Sangre (Barc) 41(2):115–123
21.
go back to reference Reiner E, Svedruzic D, Simeon-Rudolf V, Lipovac V, Gavella M, Mrzljak V (1999) Paraoxonase and arylesterase activities in the serum of two hyperlipoproteinaemic patients after repeated extracorporal lipid precipitation. Chem Biol Interact 14(119–120):405–411CrossRef Reiner E, Svedruzic D, Simeon-Rudolf V, Lipovac V, Gavella M, Mrzljak V (1999) Paraoxonase and arylesterase activities in the serum of two hyperlipoproteinaemic patients after repeated extracorporal lipid precipitation. Chem Biol Interact 14(119–120):405–411CrossRef
22.
go back to reference Iacobellis G, Assael F, Ribaudo MC, Zappaterreno A, Alessi G, Di Mario U, Leonetti F (2003) Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction. Obes Res 11:304–310PubMedCrossRef Iacobellis G, Assael F, Ribaudo MC, Zappaterreno A, Alessi G, Di Mario U, Leonetti F (2003) Epicardial fat from echocardiography: a new method for visceral adipose tissue prediction. Obes Res 11:304–310PubMedCrossRef
23.
go back to reference Silaghi AC, Poant L, Valea A, Pais R, Silaghi H (2011) Is epicardial adipose tissue, assessed by echocardiography, a reliable method for visceral adipose tissue prediction? Med Ultrason 13:15–20PubMed Silaghi AC, Poant L, Valea A, Pais R, Silaghi H (2011) Is epicardial adipose tissue, assessed by echocardiography, a reliable method for visceral adipose tissue prediction? Med Ultrason 13:15–20PubMed
24.
go back to reference Iacobellis G, Ribaudo MC, Assael F, Vecci E, Tiberti C, Zappaterreno A, Di Mario U, Leonetti F (2003) Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk. J Clin Endocrinol Metab 88:5163–5168PubMedCrossRef Iacobellis G, Ribaudo MC, Assael F, Vecci E, Tiberti C, Zappaterreno A, Di Mario U, Leonetti F (2003) Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk. J Clin Endocrinol Metab 88:5163–5168PubMedCrossRef
25.
go back to reference Kasiske BL (1988) Risk factors for accelerated atherosclerosis in renal transplant recipients. Am J Med 84(6):985–992PubMedCrossRef Kasiske BL (1988) Risk factors for accelerated atherosclerosis in renal transplant recipients. Am J Med 84(6):985–992PubMedCrossRef
26.
go back to reference Miller NE (1987) Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis. Am Heart J 113(2 Pt 2):589–597PubMedCrossRef Miller NE (1987) Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis. Am Heart J 113(2 Pt 2):589–597PubMedCrossRef
27.
go back to reference Parthasarathy S, Barnett J, Fong LG (1990) High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein. Biochim Biophys Acta 1044(2):275–283PubMedCrossRef Parthasarathy S, Barnett J, Fong LG (1990) High-density lipoprotein inhibits the oxidative modification of low-density lipoprotein. Biochim Biophys Acta 1044(2):275–283PubMedCrossRef
28.
go back to reference Draganov DI, La Du BN (2004) Pharmacogenetics of paraoxonases: a brief review. Naunyn Schmiedebergs Arch Pharmacol 369(1):78–88PubMedCrossRef Draganov DI, La Du BN (2004) Pharmacogenetics of paraoxonases: a brief review. Naunyn Schmiedebergs Arch Pharmacol 369(1):78–88PubMedCrossRef
29.
go back to reference Bełtowski J, Wójcicka G, Jamroz A (2003) Leptin decreases plasma paraoxonase 1 (PON1) activity and induces oxidative stress: the possible novel mechanism for proatherogenic effect of chronic hyperleptinemia. Atherosclerosis 170(1):21–29PubMedCrossRef Bełtowski J, Wójcicka G, Jamroz A (2003) Leptin decreases plasma paraoxonase 1 (PON1) activity and induces oxidative stress: the possible novel mechanism for proatherogenic effect of chronic hyperleptinemia. Atherosclerosis 170(1):21–29PubMedCrossRef
30.
go back to reference Patra SK, Singh K, Singh R (2013) Paraoxonase 1: a better atherosclerotic risk predictor than HDL in type 2 diabetes mellitus. Diabetes Metab Syndr 7(2):108–111PubMedCrossRef Patra SK, Singh K, Singh R (2013) Paraoxonase 1: a better atherosclerotic risk predictor than HDL in type 2 diabetes mellitus. Diabetes Metab Syndr 7(2):108–111PubMedCrossRef
31.
go back to reference Mackness MI, Mackness B, Durrington PN (2002) Paraoxonase and coronary heart disease. Atheroscler Suppl 3(4):49–55PubMedCrossRef Mackness MI, Mackness B, Durrington PN (2002) Paraoxonase and coronary heart disease. Atheroscler Suppl 3(4):49–55PubMedCrossRef
32.
go back to reference Hasselwander O, Savage DA, McMaster D, Loughrey CM, McNamee PT, Middleton D, Nicholls DP, Maxwell AP, Young IS (1999) Paraoxonase polymorphisms are not associated with cardiovascular risk in renal transplant recipients. Kidney Int 56(1):289–298PubMedCrossRef Hasselwander O, Savage DA, McMaster D, Loughrey CM, McNamee PT, Middleton D, Nicholls DP, Maxwell AP, Young IS (1999) Paraoxonase polymorphisms are not associated with cardiovascular risk in renal transplant recipients. Kidney Int 56(1):289–298PubMedCrossRef
33.
go back to reference Paragh G, Asztalos L, Seres I, Balogh Z, Löcsey L, Kárpáti I, Mátyus J, Katona E, Harangi M, Kakuk G (1999) Serum paraoxonase activity changes in uremic and kidney-transplanted patients. Nephron 83(2):126–131PubMedCrossRef Paragh G, Asztalos L, Seres I, Balogh Z, Löcsey L, Kárpáti I, Mátyus J, Katona E, Harangi M, Kakuk G (1999) Serum paraoxonase activity changes in uremic and kidney-transplanted patients. Nephron 83(2):126–131PubMedCrossRef
34.
go back to reference Iacobellis G, Bianco AC (2011) Epicardial adipose tissue: emerging physiological, pathophysiological and clinical features. Trends Endocrinol Metab 22:450–457PubMedCrossRef Iacobellis G, Bianco AC (2011) Epicardial adipose tissue: emerging physiological, pathophysiological and clinical features. Trends Endocrinol Metab 22:450–457PubMedCrossRef
35.
go back to reference Cetin M, Cakici M, Polat M, Suner A, Zencir C, Ardic I (2013) Relation of epicardial fat thickness with carotid intima-media thickness in patients with type 2 diabetes mellitus. Int J Endocrinol 2013:769175PubMedCentralPubMed Cetin M, Cakici M, Polat M, Suner A, Zencir C, Ardic I (2013) Relation of epicardial fat thickness with carotid intima-media thickness in patients with type 2 diabetes mellitus. Int J Endocrinol 2013:769175PubMedCentralPubMed
36.
go back to reference Natale F, Tedesco MA, Mocerino R, de Simone V, Di Marco GM, Aronne L, Credendino M, Siniscalchi C, Calabrò P, Cotrufo M, Calabrò R (2009) Visceral adiposity and arterial stiffness: echocardiographic epicardial fat thickness reflects, better than waist circumference, carotid arterial stiffness in a large population of hypertensives. Eur J Echocardiogr 10(4):549–555PubMedCrossRef Natale F, Tedesco MA, Mocerino R, de Simone V, Di Marco GM, Aronne L, Credendino M, Siniscalchi C, Calabrò P, Cotrufo M, Calabrò R (2009) Visceral adiposity and arterial stiffness: echocardiographic epicardial fat thickness reflects, better than waist circumference, carotid arterial stiffness in a large population of hypertensives. Eur J Echocardiogr 10(4):549–555PubMedCrossRef
37.
go back to reference Turkmen K, Kayikcioglu H, Ozbek O, Solak Y, Kayrak M, Samur C, Anil M, Zeki Tonbul H (2011) The relationship between epicardial adipose tissue and malnutrition, inflammation, atherosclerosis/calcification syndrome in ESRD patients. Clin J Am Soc Nephrol 6(8):1920–1925PubMedCentralPubMedCrossRef Turkmen K, Kayikcioglu H, Ozbek O, Solak Y, Kayrak M, Samur C, Anil M, Zeki Tonbul H (2011) The relationship between epicardial adipose tissue and malnutrition, inflammation, atherosclerosis/calcification syndrome in ESRD patients. Clin J Am Soc Nephrol 6(8):1920–1925PubMedCentralPubMedCrossRef
38.
go back to reference D’Marco LG, Bellasi A, Kim S, Chen Z, Block GA, Raggi P (2013) Epicardial adipose tissue predicts mortality in incident hemodialysis patients: a substudy of the Renagel in New Dialysis trial. Nephrol Dial Transplant 28(10):2586–2595PubMedCrossRef D’Marco LG, Bellasi A, Kim S, Chen Z, Block GA, Raggi P (2013) Epicardial adipose tissue predicts mortality in incident hemodialysis patients: a substudy of the Renagel in New Dialysis trial. Nephrol Dial Transplant 28(10):2586–2595PubMedCrossRef
39.
go back to reference Karohl C, D’Marco L, Bellasi A, Raggi P (2013) Hybrid myocardial imaging for risk stratification prior to kidney transplantation: added value of coronary calcium and epicardial adipose tissue. J Nucl Cardiol 20(6):1013–1020PubMedCrossRef Karohl C, D’Marco L, Bellasi A, Raggi P (2013) Hybrid myocardial imaging for risk stratification prior to kidney transplantation: added value of coronary calcium and epicardial adipose tissue. J Nucl Cardiol 20(6):1013–1020PubMedCrossRef
Metadata
Title
Serum paraoxonase activity is associated with epicardial fat tissue in renal transplant recipients
Authors
Eray Eroglu
Ismail Kocyigit
Aydin Unal
Hafsa Korkar
Cigdem Karakukcu
Ozcan Orscelik
Murat Hayri Sipahioglu
Bulent Tokgoz
Oktay Oymak
Publication date
01-08-2015
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 8/2015
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-015-1051-8

Other articles of this Issue 8/2015

International Urology and Nephrology 8/2015 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.